Reversible inhibitor of PAR1-mediated platelet activation
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ML-161

Item No. 15179

Technical Information
Formal Name
2-bromo-N-[3-[(1-oxobutyl)amino]phenyl]-benzamide
CAS Number
423735-93-7
Synonyms
  • AG-670
  • CID-1048267
Molecular Formula
C17H17BrN2O2
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMSO: 25 mg/mlEthanol: 25 mg/ml
λmax
240 nm
SMILES
BrC1=C(C(NC2=CC=CC(NC(CCC)=O)=C2)=O)C=CC=C1
InChi Code
InChI=1S/C17H17BrN2O2/c1-2-6-16(21)19-12-7-5-8-13(11-12)20-17(22)14-9-3-4-10-15(14)18/h3-5,7-11H,2,6H2,1H3,(H,19,21)(H,20,22)
InChi Key
DFOVLSMXPWPCFH-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    ML-161 is an allosteric, reversible inhibitor of proteinase-activated receptor 1 (PAR1) on platelets, preventing surface expression of P-selectin induced by the peptide SFLLRN with an IC50 value of 0.26 µM.1 It blocks platelet activation induced by thrombin as well as by SFLLRN but not by PMA (Item No. 10008014), U-46619 (Item No. 16450), or collagen.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Dockendorff, C., Aisiku, O., VerPlank, L., et alDiscovery of 1,3-diaminobenzenes as selective inhibitors of platelet activation at the PAR1 receptor. ACS Med. Chem. Lett. 3(3), 232-237 (2012).